MERS virus was detected in hospital air samples and swabs of hard surfaces during the height of Korea's outbreak in 2015, according to a study today in Clinical Infectious Diseases.
Exceptional Ebola surveillance and swift responses to outbreaks will be the key to taking advantage of the availability of Ebola vaccines, say three experts who offered their thoughts on the future use of such vaccines in a new article from the World Health Organization (WHO).
New studies of Ebola's long-term effects in survivors found evidence of neurologic, psychiatric, and optical problems more than a year after recovery, according to two presentations this week at the 26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
Two Ebola case-patients, both children, and one fatality in Liberia have been linked to a fatal Ebola infection in Guinea's ongoing flare-up, the World Health Organization (WHO) announced today, increasing the number of recent cases in Liberia to three.
A woman infected in Guinea's recent Ebola cluster died from her illness at a treatment center in Nzerekore, lifting the death total to eight, Agence France-Presse (AFP) reported yesterday.
Ibrahima Sylla, spokesman for Guinea's Ebola response team, told AFP that the woman died on Apr 3 and that one more confirmed case-patient is still being treated at the center. The case total in the cluster remains at nine.
The Obama administration, though, is sticking with its $1.9 billion request, some of which would cover the shift.
In what Director-General Margaret Chan, MD, MPH, of the World Health Organization (WHO) says is the most serious outbreak of yellow fever in Angola in 30 years, a serious global shortage of vaccine makes what is already a bad situation potentially catastrophic, sources are reporting. Dr. Chan recently visited Angola to observe the situation first-hand.
The new patient is a young son of a woman who recently died from her infection.
Now both Liberia and Guinea are dealing with recent flare-ups of the disease.
Experts say the world cannot ease up on efforts to fully develop Ebola vaccines.
